Indian equity benchmark indices, Sensex and Nifty, extended their losses for a second consecutive day, driven by elevated crude oil prices, persistent foreign institutional investor (FII) outflows, and high US Treasury yields.
Indian equity benchmark indices Sensex and Nifty experienced a significant tumble in early trade, primarily driven by elevated crude oil prices due to ongoing West Asia uncertainty and substantial foreign fund outflows. Track Sensex, Nifty on September 29.
Indian pharmaceutical companies are strategically increasing investments in the US market, focusing on specialty drugs, complex generics, respiratory products, and local manufacturing, despite a nearly 10 per cent fall in exports to the US in FY26 due to pricing pressure and competition in traditional generics.
Indian benchmark equity indices, Sensex and Nifty, closed higher on Monday, driven by softer-than-expected US jobs data which reduced expectations of aggressive monetary tightening by the US Federal Reserve, boosting risk appetite across emerging markets.
Indian benchmark indices Sensex and Nifty extended their losses for a third consecutive day, driven by firm crude oil prices, elevated global bond yields, and significant foreign fund outflows, making investors cautious.
Piramal Pharma anticipates a significant turnaround in financial year 2026-27 (FY27), projecting early-to-mid teens revenue expansion and a sharp improvement in profitability, driven by improved business momentum, new product acquisitions, and structural tailwinds.
India's manufacturing sector activity surged to a seven-month high in September, driven by a significant acceleration in new orders and output, leading to solid expansion in factory hiring and a four-month peak in business optimism.
The Indian stock market experienced a significant downturn, with the Sensex crashing over 1,000 points and the Nifty hitting a fresh 52-week low, driven by sustained selling from foreign institutional investors, the RBI's monetary policy tightening, and elevated Brent crude prices.
Indian benchmark indices, Sensex and Nifty, ended marginally lower after recovering from sharp intraday losses, driven by cooling crude oil prices and buying interest in HDFC Bank and IT sector stocks.
Indian benchmark indices, Sensex and Nifty, saw gains in early trade, driven by a notable drop in crude oil prices and renewed buying interest from Foreign Institutional Investors (FIIs).
The World Health Organization has requested information from the Indian government regarding the alleged supply of spurious oxytocin injections linked to the deaths of five women in Kota hospitals. This comes after regulatory action, including the cancellation of manufacturing licenses for Jackson Laboratories units, following joint inspections by drug control bodies. The government is investigating the matter, emphasising a zero-tolerance approach to quality violations.
Sun Pharmaceutical Industries Ltd has announced its acquisition of US-based Organon & Co in an all-cash deal valued at an enterprise valuation of USD 11.75 billion, aiming to become a top 25 global pharmaceutical company.
Indian benchmark indices Sensex and Nifty opened higher, extending gains from the previous session, driven by a rally in global markets and a slight cooling in crude oil prices. Optimism around a potential meeting between US and Iranian presidents also contributed to positive sentiment.Later both indices pared gains and were trading in red. Track Sensex, Nifty on September 22.
Sun Pharmaceutical Industries' Executive Chairman Dilip Shanghvi described the USD 11.75 billion acquisition of US-based Organon & Co as both a "happy" and "bit anxious" moment, acknowledging the significant debt required to fund the large transaction.
Indian benchmark indices, Sensex and Nifty, experienced a significant drop in early trade, with the Sensex falling over 600 points, primarily due to crude oil prices surging past the USD 100 per barrel mark and weak global market trends. Track Sensex, Nifty on September 24.
The Bombay High Court severely criticised the Maharashtra FDA for its "undue haste" and "high-handed" actions, forcing the regulator to withdraw orders against Cipla Pharma and five restaurants at the Mumbai Cricket Association premises. The court admonished the FDA for violating principles of natural justice and taking a "pedantic instead of pragmatic view," even threatening contempt action against officials.
The National Stock Exchange marked its stock market debut at the Bombay Stock Exchange on September 24, 2026, with a traditional gong-ringing ceremony.
Shares of Symbiotec Pharmalab Ltd, a pharma and biotech company, made a muted market debut, listing nearly 1 per cent lower on the BSE against its issue price of Rs 988, but later recovered to trade higher.
Indian benchmark indices Sensex and Nifty rebounded in early trade after three days of decline, driven by a rally in Sun Pharma following its USD 11.75 billion acquisition of US-based Organon & Co, alongside a positive trend in global equity markets.
CDSCO has warned consumers against using two unauthorised Pakistani whitening creams after finding excessive heavy metals and regulatory violations.
Indian benchmark indices, Sensex and Nifty, traded flat in early deals due to elevated crude oil prices exceeding USD 100 per barrel and persistent geopolitical tensions, which subdued investor risk appetite.
Indian benchmark indices, Sensex and Nifty, saw declines in early trade due to escalating crude oil prices and ongoing US-Iran hostilities, which subdued investor risk appetite.
At the heart of this debate is Section 3(d) of the Patents Act, a safeguard designed to prevent drugmakers from extending monopoly protection through trivial modifications to existing medicines.
India's white-collar job market experienced a 14 per cent year-on-year growth in August, with the auto, healthcare, and retail sectors leading the surge, according to a report by Naukri.com.
Five Raksha Bandhan ads that stayed with us long after the festival was over...
'India is vulnerable to the West Asia crisis in three ways: Energy costs, the business Indian companies conduct in the region, and remittances from the Indian diaspora.'
Indian benchmark indices, Sensex and Nifty, continued their downward trend for the fifth consecutive day, with the Sensex dropping 281 points and Nifty falling 78 points, primarily driven by surging crude oil prices and persistent geopolitical tensions in West Asia.
Indian stock markets closed lower due to selling in IT and FMCG shares, triggered by renewed tensions in West Asia which led to a rally in crude oil prices and concerns over inflation and interest rates.
Sun Pharmaceutical Industries' acquisition of US-based Organon & Co. for $11.75 billion, the largest overseas acquisition by an Indian pharma company, has been met with mixed reactions from brokerages, who see strategic entry into women's health and biosimilars but also flag potential integration challenges and debt concerns.
Indian benchmark indices Sensex and Nifty experienced a significant slump in early trade, mirroring a bearish trend in global equities, as escalating conflict in West Asia drove up crude oil prices and intensified investor concerns.
US Ambassador to India, Sergio Gor, highlighted the evolving US-India space partnership, moving from cooperation to "co-creation" at the Bengaluru Space Expo. He emphasised joint design, funding, and co-authoring the future of human discovery, citing the NISAR satellite and India's participation in the Artemis Accords as key examples of this growing synergy.
In the next 36 months nearly 25 to 40 per cent of jobs will be under threat from AI and job losses are inevitable.
The Maharashtra Food and Drug Administration (FDA) has cancelled the licences of 10 Ayurvedic drug manufacturing units and issued show-cause notices to 135 others following inspections that revealed serious violations including unhygienic conditions, lack of technical staff, and inadequate testing protocols.
Indian benchmark equity indices, Sensex and Nifty, closed lower for multiple consecutive days, with the Nifty extending its losses to a seventh day, primarily due to elevated crude oil prices following the expiry of the US-Iran ceasefire without a diplomatic resolution.
Indian benchmark indices Sensex and Nifty experienced declines in early trade, driven by a surge in Brent crude oil prices above USD 91 per barrel due to escalating tensions between Iran and the US, alongside an increase in US 10-year bond yields. Track Sensex, Nifty on August 18.
Indian benchmark equity indices, Sensex and Nifty, experienced declines in early trade due to elevated crude oil prices and persistent geopolitical uncertainties, particularly following the expiry of the US-Iran ceasefire. Track Sensex, Nifty on August 19, 2026.
India's pharmaceutical industry is experiencing increased bulk drug prices, particularly for APIs from China, following the escalation of the West Asia crisis in March. While current inventories provide a temporary buffer, concerns are mounting over the availability of key solvents and feedstocks, potentially leading to manufacturing disruptions and shortages in specific drug categories.
Odisha-based Serendipity Space successfully demonstrated drug crystallisation processes on a satellite prototype in a near-space mission. This breakthrough aims to enable pharmaceutical manufacturing in low Earth orbit, leveraging microgravity to create superior drug crystal structures for enhanced solubility, stability, and effectiveness. The mission tested core technologies, including an autonomous pharmaceutical factory, and was inspired by advancements made on the International Space Station.
Indian benchmark indices, Sensex and Nifty, experienced declines in early trade due to a surge in crude oil prices and significant selling pressure on bank stocks, impacting overall investor sentiment. Track Sensex, Nifty on July 22.
India's 10 most valuable families had a combined valuation of Rs 70.5 trillion.